Want to create an interactive transcript for this episode?
Podcast: Medsider: Learn from Medtech and Healthtech Founders and CEOs
Episode: Managing Critical Risks in Early-Stage Medtech: Interview with Instylla CEO Amarpreet Sawhney
Description: In this episode of Medsider Radio, we had an insightful chat with Amarpreet Sawhney, inventor, serial entrepreneur, and CEO of a few startups, including Instylla, which is developing polymerizing liquid embolics that can be used to shut down blood supply to hypervascular tumors and control bleeding.Amar is also the CEO of Rejoni, Sealonix, and Pramand. His FDA-approved inventions include ReSure Sealant and Dextenza for ophthalmology, DuraSeal for neurosurgery, FocalSeal for lung surgery, Mynx for femoral puncture sealing, and SpaceOAR for prostate cancer radiotherapy. Together, they have impacted over 8 million patients globally.In this episode...